// App-Quantinova.ai

: Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis

Researchers

Presenter

  • Ying Qiu

Principal Investigators

  • Ruizhi Zhao

  • Brandon Elpers

  • Yuexi Wang

  • Lin Xie

  • Jackson Tang

  • Aryeh Fischer

Medical Centers

  • Bristol-Myers Squibb, former employee, Princeton, United States of America

  • STATinMED Research, Ann Arbor, MI, United States of America

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

  • Interstitial lung disease

  • Pulmonary fibrosis

Biomarkers

  • N/A

Drug/Treatment

  • Pirfenidone

  • Nintedanib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved